
Twist Bioscience Corporation TWST
€ 26.47
0.39%
Geschäftsbericht 2025
hinzugefügt 17.11.2025
Twist Bioscience Corporation EV 2011-2025 | TWST
EV Jährlich Twist Bioscience Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.55 B | 2.37 B | 1.22 B | 1.16 B | 3.39 B | 5.51 B | 660 M | 236 M | 187 M | 153 M | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 5.51 B | 153 M | 1.64 B |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Brainsway Ltd.
BWAY
|
223 M | $ 17.15 | 1.06 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
433 M | $ 15.92 | 1.08 % | $ 171 M | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
35.7 M | $ 1.58 | -2.78 % | $ 2.01 M | ||
|
DarioHealth Corp.
DRIO
|
6.61 M | $ 12.15 | 2.14 % | $ 345 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
DexCom
DXCM
|
52.4 B | $ 66.09 | -1.3 % | $ 25.5 B | ||
|
Castle Biosciences
CSTL
|
665 M | $ 38.69 | 0.16 % | $ 1.07 B | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Exact Sciences Corporation
EXAS
|
12.2 B | $ 101.56 | 0.05 % | $ 18.8 B | ||
|
Danaher Corporation
DHR
|
150 B | $ 227.19 | 0.3 % | $ 166 B | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 27.03 | -0.41 % | $ 817 M | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
644 M | $ 19.92 | -3.11 % | $ 1.07 B | ||
|
Celcuity
CELC
|
506 M | $ 102.11 | -2.99 % | $ 4.03 B | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Anixa Biosciences
ANIX
|
1.5 M | $ 3.31 | -7.68 % | $ 106 K | ||
|
Co-Diagnostics
CODX
|
29.3 M | $ 0.31 | -9.31 % | $ 9.1 M | ||
|
IQVIA Holdings
IQV
|
54.8 B | $ 223.83 | 0.72 % | $ 40.6 B | ||
|
Guardant Health
GH
|
6.94 B | $ 103.97 | 1.86 % | $ 12.8 B | ||
|
Aspira Women's Health
AWH
|
42.8 M | - | -6.19 % | $ 10.5 M | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
15.3 B | $ 134.95 | 0.06 % | $ 21.5 B | ||
|
Charles River Laboratories International
CRL
|
12.4 B | $ 197.68 | 2.44 % | $ 10.2 B | ||
|
Quotient Limited
QTNT
|
393 M | - | -11.32 % | $ 1.1 M | ||
|
Mettler-Toledo International
MTD
|
33.2 B | $ 1 409.44 | 1.11 % | $ 29.9 B | ||
|
Quest Diagnostics Incorporated
DGX
|
18.5 B | $ 183.97 | 0.8 % | $ 20.4 B | ||
|
Biodesix
BDSX
|
142 M | $ 7.67 | -2.29 % | $ 995 M | ||
|
NeoGenomics
NEO
|
1.9 B | $ 12.13 | 2.32 % | $ 1.54 B | ||
|
Neogen Corporation
NEOG
|
2.26 B | $ 6.82 | -0.66 % | $ 1.48 B | ||
|
Myriad Genetics
MYGN
|
1.2 B | $ 7.03 | -2.57 % | $ 637 M | ||
|
Laboratory Corporation of America Holdings
LH
|
29.9 B | $ 262.25 | -0.73 % | $ 22 B | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 185.36 | -0.65 % | $ 15.3 B | ||
|
IDEXX Laboratories
IDXX
|
39.1 B | $ 699.6 | -0.65 % | $ 57.7 B | ||
|
Lantheus Holdings
LNTH
|
6.44 B | $ 66.88 | 0.38 % | $ 4.63 B | ||
|
Agilent Technologies
A
|
45.8 B | $ 140.28 | 0.44 % | $ 42.6 B | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.42 | -5.19 % | $ 5.56 M | ||
|
Bioventus
BVS
|
904 M | $ 7.52 | -0.46 % | $ 471 M | ||
|
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | ||
|
Pacific Biosciences of California
PACB
|
2.28 B | $ 2.12 | - | $ 538 M | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K |